Momentums Strategy Summit on Paragraph IV Litigation will include: carve-outs, estoppel, restrictions on venue, and ANDA and Biosimilars litigation. Brian’s presentation, “Assessing IP Rights Related to Biosimilars, the BPCIA, and Associated IP Litigation” will explore:

• Examining the difference between “Hatch-Waxman” (and the “BPCIA” (Biologics Price Competition and Innovation Act)
• Analyzing the participating in the “patent dance” and the disclosure of information found in the aBLA
• Exploring how participation in the dance affects the rights of a company to “seek a declaration of infringement, validity, or enforceability of any patent that claims the biological product or a use of the biological product”

Learn about the event and register here.